Skip to main content
Veterinary Medicines

EPILEPTYL

Authorised
  • Cresol C5
  • Calcium arsenicosum C15
  • CUPRUM METALLICUM C9
  • BUFO RANA C12
  • Oenanthe crocata C9
  • Coriaria myrtifolia C12
  • Veratrum viride C5
  • Cicuta virosa C15
  • Cresol C9
  • Cresol C7

Product identification

Medicine name:
EPILEPTYL
Active substance:
  • Cresol C5
  • Calcium arsenicosum C15
  • CUPRUM METALLICUM C9
  • BUFO RANA C12
  • Oenanthe crocata C9
  • Coriaria myrtifolia C12
  • Veratrum viride C5
  • Cicuta virosa C15
  • Cresol C9
  • Cresol C7
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cresol C5
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • Calcium arsenicosum C15
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • CUPRUM METALLICUM C9
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • BUFO RANA C12
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • Oenanthe crocata C9
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • Coriaria myrtifolia C12
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • Veratrum viride C5
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • Cicuta virosa C15
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • Cresol C9
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • Cresol C7
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QV03AX
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boiron
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boiron
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/4516876 7/2008
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022